Venomics AI Raises $2.7 Million to Turn Venom Into Medicine
Bengaluru-based biotechnology startup Venomics AI has raised $2.7 million, or about ₹25.5 crore, in a pre-seed round co-led by Speciale Invest and other backers, as it seeks to build a platform that uses venom-derived molecules for drug discovery. The company is positioning itself at the intersection of biotechnology and artificial intelligence, targeting a field with significant therapeutic promise but long development cycles and high scientific risk.
